Aktis, Lilly ink $1.1B cancer radiopharmaceutical deal

May 21, 2024 · The radiopharmaceutical revolution rolls on as Eli Lilly and Co. builds on its prowess in the space with a deal that could bring Aktis Oncology Inc. $1.1 billion. The two plan …

CouponFollow Extension

$1
OFF

Aktis, Lilly Ink $1.1B Cancer Radiopharmaceutical Deal

4 weeks from now

May 21, 2024 · The radiopharmaceutical revolution rolls on as Eli Lilly and Co. builds on its prowess in the space with a deal that could bring Aktis Oncology Inc. $1.1 billion. The two plan …

bioworld.com

$1
OFF

Aktis, Lilly Ink $1.1B Cancer Radiopharmaceutical Deal

4 weeks from now

May 22, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$1
OFF

Lilly Inks Potential $1.1B Radiopharma Deal With Aktis Oncology

4 weeks from now

May 21, 2024 · Lilly is also making an undisclosed equity investment in Aktis. The deal builds on previous investments in radiopharma. Lilly dropped $1.4 billion to acquire Point Biopharma in …

biospace.com

$60
OFF

Lilly Partners With Aktis, Deepening Radiopharma Investment

4 weeks from now

May 21, 2024 · Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million …

biopharmadive.com

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Eli Lilly has entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in a deal worth more than $1bn to develop novel anticancer …

pmlive.com

$1
OFF

In A $1.1B Deal, Aktis Joins Lilly To Develop ... - BioWorld

4 weeks from now

May 21, 2024 · Lilly is getting global rights to any radiopharmaceutical therapeutics and diagnostics that Aktis comes up with. Lilly will select the targets. Lilly bought Point Biopharma …

bioworld.com

$1
OFF

Lilly Bolsters Radiopharmaceuticals Portfolio Through $1.1B ...

4 weeks from now

Indianapolis, IN, May 21, 2024 (msn.com) -- In a strategic move to bolster its presence in the radiopharmaceuticals domain, Eli Lilly has forged a multi-target discovery collaboration …

jacobsmgt.com

$1
OFF

Eli Lilly Inks Radiopharma Deal Worth Up To $1.1B With Aktis - MSN

4 weeks from now

Privately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly (NYSE:LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to …

msn.com

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop New ...

4 weeks from now

May 24, 2024 · Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with Aktis Oncology. Lilly will pay $60 million in cash upfront …

purdue.edu

$60
OFF

Lilly, Aktis Sign Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

May 27, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$140
OFF

Lilly Signs $140M Radiopharma Partnership With Radionectics

4 weeks from now

Jul 1, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal The biotech hauled in a $52.5 million series A at the start of this year, bringing the total the company had …

fiercebiotech.com

FAQs about Aktis, Lilly ink $1.1B cancer radiopharmaceutical deal Coupon?

Is Eli Lilly partnering with aktis oncology?

Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million upfront. Per terms announced Tuesday, Aktis could receive as much as $1.1 billion more from Lilly if certain milestones are met. Lilly is also making an equity investment in Aktis. ...

Will Aktis partner with Lilly?

Aktis Oncology has entered into a strategic collaboration with Lilly to discover and develop targeted radiopharmaceuticals. Under the terms of the agreement, Aktis will partner with Lilly and receive a $60 million upfront cash payment, along with an equity investment in Aktis by Lilly. ...

How much money will aktis receive from Eli Lilly?

Per the terms, Boston, Massachusetts-based Aktis will receive a $60M upfront payment, an equity investment from Eli Lilly ( LLY ), in addition to potential milestone payments worth up to $1.1B. ...

How much is aktis vs Lilly worth?

On Tuesday, Lilly added more elements to its burgeoning radiopharma portfolio. Aktis took the other side of the deal, agreeing to use its platform to generate anticancer candidates against targets chosen by Lilly. The agreement is worth $60 million upfront, plus up to $1.1 billion in milestones. ...

What rights does Lilly receive from Aktis?

In exchange, Lilly will receive worldwide rights to develop radiopharmaceutical therapeutic and diagnostic products discovered by Aktis on a defined set of targets selected by Lilly. ...

What are the potential milestones Aktis can receive?

In addition to an equity investment in Aktis by Lilly, Aktis will be eligible to receive up to an additional $1.1 billion in potential preclinical, clinical, regulatory and commercial milestones, as well as tiered royalties. ...